The 20 Best Chromophobe Renal Cell Carcinoma Doctors Near Me in Stoneham, MA

Toni Choueiri is an Oncologist in Boston, Massachusetts. Dr. Choueiri is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Urothelial Cancer, Nephrectomy, and Orchiectomy.

Elizabeth Henske is an Oncologist in Boston, Massachusetts. Dr. Henske is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. Her top areas of expertise are Lymphangioleiomyomatosis, Chromophobe Renal Cell Carcinoma, Birt-Hogg-Dube Syndrome, and Renal Cell Carcinoma (RCC).

Andrew Wagner is a Urologist in Boston, Massachusetts. Dr. Wagner is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Bladder Cancer, Nephrectomy, and Cystectomy.

David Mcdermott is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Mcdermott is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Melanoma, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy.

Paul Mathew is a Hematologist in Stoneham, Massachusetts. Dr. Mathew is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Clear Cell Sarcoma. Dr. Mathew is currently accepting new patients.

Stefan Balan is an Internal Medicine specialist and an Oncologist in Winchester, Massachusetts. Dr. Balan is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Iron Deficiency Anemia, and Childhood Iron Deficiency Anemia.

Richard Lee is an Oncologist in Boston, Massachusetts. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Urothelial Cancer, Familial Prostate Cancer, Orchiectomy, and Gastrostomy.

Wenxin Xu is an Oncologist in Boston, Massachusetts. Dr. Xu is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Prostate Cancer, WT1-Related Wilms Tumor Syndromes, and Nephrectomy.

David Einstein is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Einstein is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Prostatectomy.

Glenn Bubley is an Internal Medicine provider in Boston, Massachusetts. Dr. Bubley is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Prostatectomy, and Orchiectomy.

Boris Gershman is a Urologist in Boston, Massachusetts. Dr. Gershman is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Cystectomy.

Peter Chang is a Urologist in Boston, Massachusetts. Dr. Chang is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Bladder Cancer, Urothelial Cancer, Prostatectomy, and Nephrectomy.

Dr. Graeme Steele is The Professor Walter Morris-Hale Distinguished Chair in Urologic Oncology at Brigham and Women’s Hospital, surgical oncologist at Dana-Farber Cancer Institute, and assistant professor of medicine at Harvard Medical School. He received his medical degree from the University of the Witwatersrand and completed his internship in general surgery at Johannesburg Hospital. He completed residencies in general surgery and urology at the University of Witwatersrand Medical School in Johannesburg, South Africa, and became head of their Department of Urology Medical School.In 1995, he moved to Boston and completed his urology residency at the Harvard Urology Residency Program and received his fellowship in urology at Brigham and Women’s Hospital. Dr. Steele is board certified in urology.The author of numerous clinical publications, Dr. Steele has conducted research studies focusing on benign prostatic hyperplasia, urodynamic evaluation, bladder cancer, urinary cancer and testicular cancer. His clinical specialties include: urinary incontinence, urodynamic studies, urologic oncology and voiding dysfunction. Dr. Steele is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Muscle Invasive Bladder Cancer, Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Vasectomy, and Orchiectomy.

Dr. Mossanen is a graduate of the University of California, Los Angeles (UCLA) in Los Angeles, CA and received his medical degree from the David Geffen School of Medicine at UCLA. He also holds a Master of Public Health from the Harvard T.H. Chan School of Public Health in Boston, MA. Dr. Mossanen completed a residency in Urology from the University of Washington in Seattle, WA followed by a fellowship in Urologic Oncology in the Combined Harvard Urologic Oncology Fellowship at Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Mossanen has been board certified by the American Board of Urology since 2020.His research and clinical interests include: bladder cancer, kidney cancer, kidney masses/cysts, laparoscopic surgery, penile cancer, prostate cancer, robotic surgery, testicular cancer. Dr. Mossanen is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Penile Cancer, Cystectomy, and Nephrectomy.

Peter Tiffany is a Urologist in Stoneham, Massachusetts. Dr. Tiffany is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Muscle Invasive Bladder Cancer, Vasectomy, and Ureteroscopy.

Andrea Sorcini is a Urologist in Burlington, Massachusetts. Dr. Sorcini is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Adam Feldman is a Urologist in Boston, Massachusetts. Dr. Feldman is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Urothelial Cancer, Bladder Cancer, Nephrectomy, and Cystectomy.

Douglas Dahl is a Urologist in Boston, Massachusetts. Dr. Dahl is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Prostatectomy, and Nephrectomy.

Marc Michaelson is an Oncologist in Boston, Massachusetts. Dr. Michaelson is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, Orchiectomy, and Nephrectomy.

Xin Gao is an Oncologist in Boston, Massachusetts. Dr. Gao is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, and Colonoscopy.